In VivoRiding high on the wave of its dual GIP/GLP-1 agonist, tirzepatide, Eli Lilly awarded its CEO the highest total remuneration package of the top 12 big pharma companies in 2024. David Ricks’s total com
ScripTeva Pharmaceutical Industries – best known as a generic drug leader – has been focused on building an innovative drug portfolio, a key pillar of CEO Richard Francis’s “pivot to growth” strategy. The
ScripData from the Phase III GENEr8-1 trial testing BioMarin’s Roctavian in patients with severe hemophilia A over a period of five years showed that the gene therapy maintained durable bleed control and s
ScripNovartis’s Cosentyx has amassed approvals for multiple dermatological and rheumatological conditions since its first green light in 2015 for psoriasis but a bid to add giant cell arteritis (GCA) to th